Log in to save to my catalogue

Proapoptotic Peptide-Mediated Cancer Therapy Targeted to Cell Surface p32

Proapoptotic Peptide-Mediated Cancer Therapy Targeted to Cell Surface p32

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3863797

Proapoptotic Peptide-Mediated Cancer Therapy Targeted to Cell Surface p32

About this item

Full title

Proapoptotic Peptide-Mediated Cancer Therapy Targeted to Cell Surface p32

Publisher

United States: Elsevier Inc

Journal title

Molecular therapy, 2013-12, Vol.21 (12), p.2195-2204

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Antiangiogenic therapy is a promising new treatment modality for cancer, but it generally produces only transient tumor regression. We have previously devised a tumor-targeted nanosystem, in which a pentapeptide, CGKRK, delivers a proapoptotic peptide into the mitochondria of tumor blood vessel endothelial cells and tumor cells. The treatment was h...

Alternative Titles

Full title

Proapoptotic Peptide-Mediated Cancer Therapy Targeted to Cell Surface p32

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3863797

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3863797

Other Identifiers

ISSN

1525-0016

E-ISSN

1525-0024

DOI

10.1038/mt.2013.191

How to access this item